HCM
HUTCHMED
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · HK
$14.18
+0.93%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 40.70x
- P/E 2027E
- 30.80x
- P/E 2028E
- 25.46x
- P/S forward
- 3.16x
Trailing multiples
Trailing twelve months
- P/E TTM
- 144.69x
- PEG TTM
- —
- Price / book
- 1.96x
- Price / sales
- 4.51x
- Price / cash flow
- 120.92x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 2.20x
- EV / EBITDA
- -58.80x
- EV / EBIT
- -34.68x
- Market cap
- $2.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026